C4 Therapeutics Inc.

NASDAQ: CCCC · Real-Time Price · USD
1.64
0.00 (0.00%)
At close: May 01, 2025, 3:59 PM
1.58
-3.33%
After-hours: May 01, 2025, 07:26 PM EDT

C4 Therapeutics Revenue

C4 Therapeutics reported an annual revenue of $35.58M, reflecting a 71.44% growth. For the quarter ending December 31, 2024, C4 Therapeutics generated $5.18M in revenue.
Revenue (ttm)
$35.58M
Revenue Growth
71.44%
Price / Sales Ratio
7.02
Revenue / Employee
$323.49K
Employees
110
Market Cap
116.1M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 35.58M +71.44%
Dec 31, 2023 20.76M -33.25%
Dec 31, 2022 31.1M -32.08%
Dec 31, 2021 45.78M +37.93%
Dec 31, 2020 33.2M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.